Legal Representation
Attorney
Maury M. Tepper, III
USPTO Deadlines
Application History
27 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 8, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| May 8, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Oct 19, 2022 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Oct 6, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 4, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 4, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 4, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 3, 2022 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Apr 5, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 8, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 8, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 19, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 6, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 6, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 6, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 6, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 6, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 16, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 16, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 16, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 19, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 19, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 19, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 18, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 6, 2021 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 5, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 4, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of hypothyroidism, thyroid hormone deficiency, myxedema and thyroid tumors
Additional Information
Design Mark
The mark consists of a stylized infinity symbol followed by the text THYQUIDITY above the text "(LEVOTHYROXINE SODIUM)" above the text "100MGC/5ML".
Pseudo Mark
THYQUIDITY (LEVOTHYROXINE SODIUM) ORAL SOLUTION ONE HUNDRED MICRO GRAMS FIVE MILLILITERS; THYQUDITY (LEVOTHYROXINE SODIUM) ORAL SOLUTION ONE ZERO ZERO MICROGRAM/FIVE MILLILITERS
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"(LEVOTHYROXINE SODIUM) ORAL SOLUTION 100 MCG/5ML"